Paraproteinemia-associated scleredema treated successfully with intravenous immunoglobulin.
Harvard Combined Dermatology Residency Program, Boston, Massachusetts2Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts3Harvard Medical School, Boston, Massachusetts.
A Brooke
AB
Eastham
Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts3Harvard Medical School, Boston, Massachusetts.
Alisa N
AN
Femia
Harvard Combined Dermatology Residency Program, Boston, Massachusetts2Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts3Harvard Medical School, Boston, Massachusetts.
Nicole F
NF
Velez
Division of Hematology, Department of Medicine, Tufts Medical School, Boston, Massachusetts.
Hedy P
HP
Smith
Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts3Harvard Medical School, Boston, Massachusetts.
Ruth Ann
RA
Vleugels
D000328:Adult; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007155:Immunologic Factors / Q000627:therapeutic use*; D008875:Middle Aged; D010265:Paraproteinemias / Q000150:complications / Q000188:drug therapy*; D016059:Range of Motion, Articular; D012592:Scleredema Adultorum / Q000150:complications / Q000188:drug therapy*
D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors